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Summary 
 
The Smoothened (Smo) signalling pathway participates in many developmental 
processes, contributing to the regulation of gene expression by controlling the activity 
of transcription factors belonging to the Gli family.  The key elements of the pathway 
were identified by means of genetic screens carried out in Drosophila, and subsequent 
analysis in other model organisms revealed a high degree of conservation in both the 
proteins involved and in their molecular interactions.  Recent analysis of the pathway, 
using a combination of biochemical and cell biological approaches, is uncovering the 
intricacies of Smo signalling, placing its elements in particular cellular compartments 
and qualifying the molecular processes involved.  These include the synthesis, secretion 
and diffusion of the ligand, the activation of the receptor and the modifications in the 
activity of nuclear effectors.  In this review we discuss recent advances in understanding 
biochemical and cellular aspects of Smo signalling, with particular focus in the 
similarities in the mechanism of signal transduction between Smo and other 
transmembrane proteins belonging to the G-Protein coupled receptors superfamily 
(GPCR). 
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1. Biological roles of Hh/Smo signalling during development and disease 
 
The components of the Smo signalling pathway were identified by their similar 
requirements during embryonic segmentation and appendage development in 
Drosophila [1, 2].  Since then, the number and variety of developmental processes 
requiring Smo function has increased enormously, both in Drosophila and vertebrates 
[3-7].  Most often Smo functions during embryonic development, in processes such as 
digit patterning in the chick limb bud and left–right asymmetry of vertebrate embryos.  
In addition, Smo function is also fundamental for the maintenance of tissue homeostasis 
in adults, and deregulated Smo signalling is implicated in tumorogenesis.  Most of the 
elements of the Smo pathway have been identified through genetic screenings carried 
out in Drosophila and, more recently, by the use of systematic searches in cell culture 
experiments [8, 9].  Simultaneously, the use of biochemical approaches has unravelled 
many of the complexities of the pathway, allowing a partial understanding of the 
molecular interactions that translate the binding of the ligand Hedgehog (Hh) to its 
receptor Patched (Ptc) into the functional state of the transcription factor Cubitus 
interruptus (Ci), and hence to the regulation of gene expression in response to Hh [10].   
Most of the elements of the pathway are conserved from flies to vertebrates, the 
main difference being the number of related genes present in different organisms [7].  
Thus, there is only one Hh gene in flies and three Hh-related genes in vertebrates, sonic-
hedgehog, desert-hedgehog and indian-hedghog, which are expressed in different 
tissues and stages of development [11].  Similarly, there is only one gene encoding the 
receptor Ptc in Drosophila and two Ptc proteins (PTC1 and PTC2) in vertebrates (Table 
1).  The main effectors of Smo signalling, the Gli proteins related to Drosophila Ci, are 
also conserved in vertebrates, where at least three Gli proteins are found (GLI1, GLI2 
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and GLI3).  In the mouse, these proteins mediate all Hh-dependent patterning in the 
neural tube [12, 13].  Like Ci, all three vertebrate Gli proteins have five highly 
conserved zinc finger DNA binding domains and C-terminal activation domains, with 
Gli2 and Gli3 also having N-terminal repressor domains [12, 14].  Gli3 truncations, 
point mutations, and frame shifts changes in human Gli3 lead to a variety of diseases 
including Greig cephalopolysyndactyly syndrome (GCPS) [15-17], Pallister-Hall 
syndrome (PHS) [18], and postaxial polydactyly type A (PAP-A) [19].  
Despite the conservation in the components of Smo pathway during evolution, 
some caveats remain as to the preservation of the key molecular mechanisms operating 
in different organisms [20].  Particularly perplexing has been the difficulties in relating 
the mechanisms of Smo signal transduction to that of other transmembrane proteins 
with a similar molecular structure, the G-protein coupled receptor (GPCR) superfamily 
of seven transmembrane domains proteins. 
In this review we will summarize recent advances in the identification of the 
molecular mechanisms involved in Smo signal transduction, emphasizing the 
relationships between Smo and other GPCRs, and the participation in Smo signalling of 
several components of classic GPCR pathways, such as heterotrimeric G-proteins, β-
arrestins and G-protein coupled receptor kinases (GRKs). 
 
2. The elements of the Smo signalling pathway and the mechanisms of Smo signal 
transduction. 
 
The core members of the Smo signalling pathway include the ligand (Hedgehog, 
Hh), the receptor (Patched, Ptc), several transducers such as Smoothened (Smo) and the 
cytoplasmic complex formed by the kinesin-like protein Costal-2 (Cos2), the 
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serine/threonine kinase Fused (Fu), the novel protein Suppressor of fused [Su(fu)], and 
the transcription factor Cubitus interruptus (Ci) [7, 21].  In addition, several proteins 
participate in the correct secretion and movement of active Hh, in the phosphorylation 
of Ci and Cos2, and in the processing and degradation of Ci [21, 22].  In this manner, 
the Smo pathway can be sub-divided into several “molecular modules” participating in 
(i) the formation, secretion and movement of active Hh, (ii) the intracellular trafficking, 
sorting and recycling of Hh/Ptc/Smo complexes, (iii) the relay complex formed by 
Cos2, Fu, Ci and in some instances Su(fu), and (iv) the enzymatic machinery that by 
phosphorylation (GSK3, CKI and PKA) or proteolysis (Slimb) modulates the activities 
of Smo, Cos2, Fu and Ci (Table 1 and Fig. 1).   
The final outcome of Smo signalling consists in modifications to the stability, 
phosphorylation and subcellular localisation of the transcription factor Ci/Gli, in a 
process regulated by post-transcriptional modifications to Ci.  The transition of Ci from 
the “inactive” state (repressor form), defined by the presence in the nucleus of the 
processed form Ci-75 and the cytoplasmic accumulation of Ci (Fig. 1A), to the “active” 
state (activator form), characterized by the presence in the nucleus of full-length Ci-155 
and the absence of Ci-75, is triggered by interaction between the receptor Ptc and the 
ligands of the Hedgehog (Hh) family (Figure 1B).  These ligands are secreted proteins 
synthesized as precursors containing a signal peptide, and possess auto-proteolytic 
activity [7] (Figure 1C).  In addition, after its synthesis and before their apical secretion 
to the extracellular space, Hh proteins are modified by the addition of lipid molecules 
[22].  Thus, Hh is cleaved in an autoproteolytic reaction and a cholesterol molecule is 
incorporated in its C terminus of the N-terminal fragment, giving rise to the Hh-Np 
active form [22].  A second lipid modification is the addition of palmitic acid the N 
terminus of Hh-Np, in a reaction catalysed by the acyl transferase Rasp [23, 24].  The 
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analysis of mutated forms of Hh in flies suggests that absence of cholesterol-
modification in Hh-Np affects its secretion, multimerization and long-range signalling 
activity [25, 26], as was previously recognized in mammalian systems [27-29].  
Similarly, the lack of acylation reduces dramatically Hh signalling, both in Drosophila 
and vertebrates. 
Once Hh is modified by lipids, it must be secreted to the extracellular space.  It 
has been shown that the protein encoded by the gene dispatched (disp) is required to 
liberate lipid-modified Hh from Hh producing-cells [27, 30].  Thus, disp mutant cells 
retain lipid-modified Hh, whereas unmodified Hh-N is secreted independently of Disp 
function.  Disp contains, like Ptc, twelve transmembrane domains and a sterol-sensing 
domain (SSD), which has been involved in cholesterol homeostasis and cholesterol-
linked signalling [22].  
Hh interacts with the twelve-pass transmembrane receptor Patched (Ptc) of 
neighbouring cells, and the range of Hh diffusion and effectiveness varies in different 
developmental systems [31-35].  Extracellular matrix proteins such as heparan sulfate 
proteoglycans (HSPGs) participate in the movements of Hh once it has been secreted, 
and might contribute to the presentation of Hh to its receptor Ptc.  Thus, the Drosophila 
EXT family of proteins encoded by the genes tout velu (ttv), brother of tout velu (botv) 
and sister of tout velu (sotv) are essential for the synthesis of HSPGs and are required 
for the diffusion of lipid-modified Hh [36, 37].  The proteins Dally and Dally-like (Dlp) 
are glypicans forming the HSPGs core, and are also required for Hh diffusion [38, 39].  
Another protein recently implicated in the spreading of Hh is a secreted protein encoded 
by the gene shifted (shf), that is required for normal accumulation of Hh in the 
extracellular matrix of Hh-producing cells and for lipid-modified Hh diffusion [40, 41].  
Shf is the ortholog of the human Wnt inhibitory factor (WIF), a secreted antagonist of 
 7 
the Wingless pathway.  However, Shf has not effect on Wingless activity in Drosophila.  
Finally Megalin, a multi-domain transmembrane protein [42], and a novel and 
evolutionarily conserved family of transmembrane proteins containing Ig domains and 
two extracellular fibronectin type III domains, CDO and BOC, bind to Hh, and might 
function as co-receptors in Hh reception [43-45]. 
The interaction between Hh and Ptc releases the repression that Ptc exerts on 
Smo, allowing the activation of downstream components. The mechanism of Smo 
activation includes the internalisation of Hh/Ptc/Smo complexes from the cell 
membrane, the sorting of Hh/Ptc from Smo in endocytic vesicles, the phosphorylation 
of Smo by several Ser/Thre kinases including CKI and PKA and the accumulation of 
phosphorylated Smo in basolateral cell membranes [10, 21] (Figure 1B).  The 
intracellular trafficking of Ptc and Smo through the late endosome–lysosome system is 
thought to be critical for the regulation of Smo activity by Ptc [46], although the 
analysis of a Drosophila mutant Ptc protein defective in Hh internalisation suggests that 
Hh internalisation and Smo signalling can be uncoupled [47].  It has been suggested that 
Ptc, in the absence of Hh and acting in a similar manner to other proteins containing 
Sterol-sensing domains, directs Smo to a cellular compartment where it is targeted for 
degradation [48-50].  The exposure of cells expressing Ptc and Smo to Shh leads to the 
co-internalisation of Ptc, Smo and Shh, and to the degradation of Ptc and Shh in 
lysosomes [51]. Thus, after entering late endosomes together, Smo is segregated from 
the Ptc–Shh complex, and returns to the cell surface, where it is now ready to signal 
[51].  Interestingly, constitutively active mutant Smo proteins that are not inhibited by 
Ptc (isolated from sporadic basal cell carcinomas), fail to co-localise and co-internalise 
with Ptc, allowing the activation of the pathway independently of Hh [50].   
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Once activated, the interactions between Smo and the cytoplasmic complex 
formed by Cos2, Fu, Su(fu) and Ci changes in a way that the processing and 
degradation of Ci stops, allowing the accumulation of full-length Ci and its entrance 
into the nucleus, where it can bind DNA and regulate the expression of its target genes 
[7, 21].  Hh does not alter Smo–Cos2 affinity, but it does increase the total amount of 
Smo–Cos2 complex and alter its location.  Thus, in the absence of Hh, or when Ptc is 
present in excess, Smo is localised in cytoplasmic vesicles, and Cos2 scaffolds multiple 
kinases, increasing the accessibility of Ci to these kinases and facilitating extensive 
phosphorylation of Ci by PKA, CKI and GSK3, targeting Ci for proteolytic processing 
mediated by the ubiquitin ligase Slimb ([52]; Fig. 1A).  Dbr enhances poly-
ubiquitination of Ci, promoting its degradation [53] (Fig. 1A).  In this manner Ci is 
either degraded by the proteosome, or converted into a 75 Kd form (Ci-75) that enters 
the nucleus and represses the transcription of target genes (Fig. 1A).  In the presence of 
Hh, or when Ptc is absent, Cos2 complexes are recruited to the cell surface via Smo, and 
its components Cos2, Fu and Su(fu) become phosphorylated by the Fu kinase, among 
others [54] (Fig. 1B).  This leads to the disassembly of Cos2-Ci-kinase complexes. As a 
consequence, Ci phosphorylation is compromised and Ci processing does not take 
place, allowing the accumulation of the full-length form of Ci (Ci-155) in the cytoplasm 
and its entrance into the nucleus [55-60].  A significant fraction of Su(fu) associates 
with Ci, whereas a smaller fraction may also associate with Cos2 and Fu, in at least two 
distinct complexes, one comprising Ci/Su(fu) and another Cos2/Fu/Ci/Su(fu) [61].  In 
this scenario, Cos2 plays a key role in the transition from Ci-75 to Ci-155 through 
interactions with Smo.  Early studies of Cos2 identified a negative role for Cos2 in 
pathway regulation, because cos2 mutations caused inappropriate activation of 
signalling [62, 63].  This antagonism is due to the requirement of Cos2 for both 
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cytoplasmic retention of Ci and its proteolytic processing to produce Ci-75 [64-66].  
More recently, additional requirements for Cos2 have been identified, including the 
stabilization of Fu and the accumulation of activated Smo.  The transition of Cos2 from 
a pathway suppressor to activator requires adequate levels of activated Smo, and it has 
been proposed that Cos2 acts as a scaffold and sensor that, by transducing pathway 
activation from Smo to Ci, actively participates in the transition of Ci from the inactive 
to the active state [60].  
Although some details of the molecular interactions that participate in Ci 
modifications are still lacking, it is clear that Hh binding to Ptc triggers modifications in 
Smo that alter its stability and subcellular localisation, shifting the Cos2/Fu/Su(fu) 
complex from a state that promotes the formation of Ci-75 to another state in which the 
accumulation of Ci-155 is favoured, leading to changes in the expression of genes 
containing Ci-binding sequences (Figure 1B).  In what follows, we will consider the 
similarities between Smo and other proteins of the GPCR superfamily, and discuss the 
possibility of shared mechanisms regulating Smo and other GPCRs. 
 
3. Smoothened as a member of the GPCR family 
 
The super-family of G-protein coupled receptors (GPCRs) is one of the largest 
families of proteins in vertebrates, with circa 1000 genes encoding for such receptors 
identified in the human genome [67-69].  GPCRs participate in a variety of important 
physiological functions and are targets for many drugs. The ligands that activate GPCRs 
are molecularly diverse, and include ions, organic odorants, amines, peptides, proteins, 
lipids, and nucleotides.  In addition many GPCRs have also been denominated ‘orphan 
receptors’, because their natural ligands have escaped identification so far [13].  The 
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main structural characteristic of the family is the seven membrane-spanning  -helices 
(TMHs), which span the membrane in an anti-clockwise manner and are formed by 25-
35 consecutive amino acid residues with some degree of hydrophobicity. These helices 
are connected by extracellular and intracellular hydrophilic loops, with an extracellular 
N-terminus and a cytoplasmic C-terminus.  Most GPCRs, as its name indicates, mediate 
their intracellular actions through pathways involving interaction and activation of 
heterotrimeric G-proteins, although G-protein-independent signaling mechanisms have 
also been reported for some GPCRs.  In addition several non-GPCR receptors use 
heterotrimeric G-proteins and other cytoplasmic proteins related to GPCR activity as 
transducers in their signaling.  For these reasons, some authors used alternative names 
for this protein superfamily such as “7-transmembrane receptors”, “serpentine-like 
receptors” or “heptahelical receptors” [70-72]. 
The Hh/Smo signaling pathway differs in several aspects from the canonical 
mechanisms of 7-transmembre receptors activation.  Smo lacks the ability to directly 
interact with the secreted ligand, and uses Ptc as the receptor for Hh.  In this case, 
receptor activation involves the release of Smo from Ptc inhibition, triggered by Hh/Ptc 
interactions, and the intracellular sorting of activated Smo from Hh/Ptc complexes [51].  
However, several features of the Smo pathway are related to those of the GPCR 
superfamily and are discussed below, including structure and membrane localisation, 
the possible implication of dimerization in its mode of activation, and the existence of 
post-transcriptional modifications and internalisation mechanisms from the cell 
membrane in the presence of ligand. 
 
3.1 Smoothened receptor structure and sequence similarity 
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All published classifications of GPCRs superfamily members based on sequence or 
structural features include the Frizzled and Smo receptors as related to the GPCR 
secretin family [73-76].  Both Frizzled and Smo receptors display low but significant 
sequence similarity to other GPRCs of the secretin family particularly in their 
transmembrane domains [77, 78].  The alignment of representative members of the Fz, 
secretin and Smo receptors is presented in Figure 2.  The Smo protein has a long extra-
cellular N-terminal domain about 250 amino acids long, and presents a conserved 
cystein-rich domain (CRD).  The cysteines in this domain are predicted to be essential 
for acquiring the correct tertiary structure.  In the Smo-related Fz receptor, the CRD 
binds its ligand, the Wnt protein [79].  Although the CDR of Smo binds neither Wnt nor 
Hh protein [80], its evolutionary conservation suggests that it may have an important 
role in Smo regulation, which has yet to be determined.  Interestingly, the missense 
mutation Cys90Ser, localised in the CRD of the extra-cellular domain of Drosophila 
Smo, is associated with a weak Smo loss of function phenotype [50], suggesting that the 
occurrence of correct disulphide bridges within the CRD are needed for Smo activity.  
The CRD domain may also be required for the interaction between Smo and Ptc.  In this 
sense, some reports have shown a weak interaction between PTC and the CRD of Smo, 
and both proteins can be co-inmunoprecipitated when over-expressed [81].  Direct 
interactions between Smo and Ptc, however, have not been detected under physiological 
conditions [82], probably reflecting that this interaction is weak and transient.  In 
addition, Ptc and Smo show minimal co-localisation within the cell, and their 
interaction is not stechiometric, as Ptc is able to inhibit excess of Smo [46, 50, 82, 83]).  
Other motifs of homology with the Secretin family shared by Smo and Fz are located 
between the transmembrane regions of these proteins.  
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3.2  Seven-transmembrane receptors dimerization 
 
GPCRs have traditionally been thought to act as monomers, but now is widely 
accepted that GPCRs may exist as either homodimers or even higher-order oligomers.  
They are also capable of interacting with distantly related receptor subtypes to form 
hetero-oligomers and, for many members of this receptor family, the dimer may 
represent the basic signaling unit during their normal intracellular trafficking and 
function (reviewed in [84-86].  Certain GPCRs seem to have a strict requirement for 
heterodimerization to attain proper surface expression and functional activity such as 
the GABAB receptor [87].  Heterodimerization can also lead to marked changes in 
receptor pharmacology, signaling, and/or internalisation.   
There is not direct data demonstrating Smo dimerization, but several 
observations concerning Smo and the related Frizzled (Fz) receptors suggest that they 
also operate as dimers or multimers.  Thus, ectopic expression of Smo variants with C-
terminal deletions cause dominant-negative effects, and increased expression of full-
length Smo results in ectopic activation of the pathway [88].  More recently, it has been 
hypothesized that the highest level of Smo activity might involve Smo dimerization 
[89].  Smo dimers would interact with Cos2-Fu-Ci-Su(fu) complexes, activating Su(fu) 
phosphorylation by Fu, and releasing the inhibition on Ci.   
 
3.3. Coupling of Smo to heterotrimeric G-proteins 
 
There are several evidences pointing to a role of heterotrimeric G-proteins as Smo 
effectors in vertebrates.  First, Smo is constitutively active in the absence of Ptc, and the 
third intracellular loop and the seventh transmembrane region of Smo are required for 
 13 
this function [90].  Both domains are very important in other GPCRs for coupling with 
heterotrimeric G-proteins.  Assays made in frog melonophores expressing human Smo 
showed a phenotype of persistent pigment aggregation, and this effect can be blocked 
by pertussis toxin [91], a treatment known to ADP-ribosylate a cysteine residue near the 
carboxyl terminus of Gαi or Gαo, disrupting receptor-G protein coupling [92].  These 
results suggest that Smo can signal through heterotrimeric G-proteins.  In fact, it has 
been recently shown that Smo activates all members of the Gαi family, and this effect is 
an essential component of Gli activation in mammalian fibroblasts [93].  In the same 
line, injection of Zebrafish embryos with RNA encoding pertussis toxin and therefore 
blocking Gαi-mediated actions suggests a possible role for in Smo signaling [94]. 
Further support for a role of heterotrimeric G proteins in Smo signal transduction is the 
reported transcriptional stimulation of a Gli1 promoter in HEK293 and N2a cells over-
expressing constitutively active Gα [95].  These data reveal that the 
Gα12/13/RhoA/RhoA kinase pathway participates in Smo signaling.  Indirect support for 
the involvement of RhoA in Smo signaling is provided by the analysis of moesin 
mutants in Drosophila.  Moesin, encoding the only member in Drosophila of the 
Radixin/Ezrin/Moesin family, is required for correct epithelial development and its loss-
of-function alleles cause inappropriate Smo signaling. These effects can be reverted by 
reducing the dose of the RhoA GTPase [96].   
Finally, several mutations in Smo that promote some phenotypic features 
coincident with those of canonical GPCRs provide additional support for Smo/G-
protein coupling.  A somatic missense mutation in human Smo, caused by an amino 
acid substitution in the seventh transmembrane domain (Trp535Leu), a site predicted to 
disrupt G-protein coupling [97], cause Smo activation.  Similarly, a smo loss of function 
phenotype can be generated by the K474C missense mutation in Smo, which changes an 
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Arg residue localized in the third intracellular loop, close to the boundary with 
transmembrane TM6.  This mutation is similar to other found to abolish G-protein 
coupling in other GPCRs [50], indicating an important role for these domains in Smo 
function. 
However other data suggest that G-proteins are not always required for Smo 
signaling.  In vitro studies using a primary fish myoblast assay system reveal that the 
response to Shh is insensitive to pertussis toxin treatment.  Moreover, there is to date no 
report of mutations in a Drosophila G-protein giving a phenotype reminiscent of Smo 
signaling disruption [94], and studies using RNA interference to inhibit a full spectrum 
of G-protein subunits in Drosophila tissue culture cells failed to compromise Hh 
signaling [8].  The observed coupling of Smo to Gαi-proteins occurring in particular 
cell types could be part of a mechanism used to reduce PKA activity by decreasing the 
level of cAMP, preventing Gli phosphorylation and amplifying Smo signaling.  
Additional inputs from Smo to Gli contributing to pathway activation depend on the 
integrity of the C-terminal domain of Smo and might be mediated by Smo 
phosphorylation by GRK2 (see below).  In addition, the effects on Smo signaling 
caused by G protein activity modifications could be indirect, based on changes on 
cytoskeleton architecture or vesicular trafficking mediated by these proteins. 
 
4. Smo phosphorylation 
 
Drosophila Smo activation is accompanied by its phosphorylation, accumulation 
and translocation to the plasma membrane [46, 50, 59, 98-100].  When Hh is present, 
the Smo C-terminal tail becomes hyper-phosphorylated by protein kinase A (PKA) and 
Casein kinase I (CKI) (see Fig 1B).  Loss of these PKA or CK1 sites, using un-
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phosphorylatable (Ser/Thr→A) forms of Smo renders Smo inactive, whereas changes of 
multiple serine residues to acidic residues (Ser/Thr→D mutants, phosphorylation-
mimicking forms) activate signaling even in the absence of Hh [98-100].  Zhang and 
collaborators [99] identified 26 serine and threonine residues within the Drosophila 
Smo C-terminal cytoplasmic tail (marked with asterisks in Figure 2) that become 
phosphorylated upon Hh stimulation in S2 Drosophila cell lines.  There are some 
identified phosphoserine and phosphothreonine residues that lye in consensus kinase 
recognition motifs for PKA, CKI and GSK3 among others, but there are also 
phosphoresidues that do not belong to consensus motifs for any of these kinases.  Most 
of these Smo phosphorylated residues are not conserved in vertebrates, suggesting that 
activation of vertebrate Smo is not triggered by PKA and CKI phosphorylation.  Thus, 
other kinases might play a role in vertebrate Smo activation and, in fact, in vitro 
approaches using mammalian cell culture models revealed that upon Hh stimulation, 
Smo protein is phosphorylated by the G protein-coupled receptor kinase GRK2 [101].  
As it happens for other GPCRs, phosphorylation of Smo by GRK2 promotes binding of 
β-arrestin-2 and Smo internalisation (see below).  This observation suggests that 
different sets of kinases might be implicated in regulating Smo activity in vertebrates 
and Drosophila.   
Interestingly, a Drosophila Smo mutant with acidic residues in place of PKA and 
CK1-targeted serine residues can be further activated by Hh treatment, indicating that 
additional changes in Smo can be induced by Hh, conceivably involving additional 
phosphorylation sites [98-100].  Some of those identified residues are in the vicinity of 
acidic residues that fit a “GRKs phosphorylation consensus-sequence” observed in both 
plasma membrane receptors and cytoplasmic substrates of GRK2 [102-106].  Some of 
these phosphorylated residues are present both in Drosophila and in vertebrate Smo C-
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terminal cytoplasmatic tails (Ser 633, 634, 680, 746; Figure 2 mark as square) [99], 
suggesting that GRK phosphorylation of Smo might be conserved in Drosophila and 
vertebrates.  
 
5. Implication of the canonical GPRC signaling components GRK and β-arrestin 
in Smo signaling  
 
In the last two years a new connection has been established between Smo 
signaling and some proteins involved in canonical GPCR regulation and signaling: the 
cytosolic β-arrestin proteins and the G protein-coupled receptor kinase GRK [96, 101, 
107].  Canonical GPCR stimulation promotes the activation of heterotrimeric G 
proteins, and triggers receptor phosphorylation in Ser/Thr residues by GRKs. β-arrestins 
then bind to the phosphorylated receptor, leading to (i) impaired communication of the 
receptor with the G protein even in the presence of stimulus, (ii) induction of clathrin-
mediated receptor internalisation, mediating its coupling to the endocytic machinery.  
Internalised receptors can then be dephosphorylated by the action of specific 
phosphatases in low pH endosomes and recycled to the plasma membrane 
(resensitization), or be degraded in lysosomes [101, 108-110]. In addition, binding of β-
arrestins can recruit additional proteins to the membrane, acting as signal transducers 
through the formation of scaffolding complexes with accessory effector molecules such 
as Src, Raf, ERK1/2, JNK3, MAPK4 and p38 [111-116].  
The implication of β-arrestin and GRKs in modulating protein activity and 
localisation is not exclusive to GPCRs.  For example, the non-visual arrestin of 
Drosophila encoded by Kurtz interacts with the putative E3 ubiquitin ligase Deltex, and 
promotes ubiquitination and degradation of the Notch receptor [117].  Arrestin also 
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constitutes an essential component in the signaling pathways initiated by the insulin-like 
growth factor 1 (IGF-1) by promoting ubiquitination of the receptor by the E3 ubiquitin 
ligase oncoprotein MDM2 [116].  β-arrestin2 can also bind to the single 
transmembrane-spanning type II TGF  receptor, and its binding is triggered by 
receptor auto-phosphorylation [101, 105].  
In addition to arrestin, GRK proteins have also been involved in the modulation of 
both non-GPCR receptors and other non-receptor proteins.  Thus, GRKs are able to 
phosphorylate non-receptor substrates such as tubulin, synucleins, phosducin, ribosomal 
protein P2, the inhibitory -subunit of the type 6 retinal cGMP phosphoriesterase, a 
subunit of the epithelial Na+-channel and ezrin [68, 102, 105, 106, 118-121].  GRKs 
also participate in several pathways and modulate cellular functions in a 
phosphorylation-independent manner.  These actions of GRKs are due to their ability to 
interact with a variety of proteins involved in signaling and trafficking, such as Gαq, 
Gβ , caveolin, or GIT [122-124].  Finally, arrestins and GRKs also participate in 
several signaling platforms regulating other receptor families, such as tyrosine kinase 
receptors [125, 126].  
The secretin receptor, belonging to the same family of GPCR as Smo and Fz, can 
be phosphorylated by GRK2 and GRK5 upon binding of agonists, promoting its 
desensitization [127].  Secretin is not the only member of this family that becames 
phosphorylated by GRKs upon agonist stimulation.  Smo over-expression in 
mammalian cultured cells recruits β-arrestin2 to the plasma membrane [101].  A 
regulatory role for β-arrestin 2 in the Hh signaling pathway has also been described in 
vivo.  Thus, functional knockdown of β-arrestin 2 by morpholino depletion in zebrafish 
embryos lead to phenotypes similar to those resulting from mutants in the Hh pathway, 
indicating a functional interaction between β-arrestin2 and Smo [107].  This interaction 
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was demonstrated in mammalian cell culture experiments, which showed that both β-
arrestin and GRK2 mediate clathrin-dependent internalisation of active Smo.  
Furthermore, Ptc, as well as the antagonist cyclopamine, inhibits the association of β-
arrestin 2 with Smo, and this inhibition is relieved in cells treated with the agonist Shh 
[101].  Finally, a direct requirement of mammalian GRK2 in Smo signalling has been 
identified in C3H10TI/2 cells, where GRK2 promotes coupling of β−arrestin and Smo 
[128].  Because the integrity of the Smo C-terminal, in addition to G-protein coupling, 
is necessary for Gli activation [93], it is tempting to speculate that GRK2 activity acting 
through the Smo C-terminal domain is a key component of Smo pathway activation. 
The vertebrate β-arrestins and GRK proteins have homologous genes in 
Drosophila, although their functional characterisation has not yet being reported for 
most of them.  There are two GRKs in Drosophila, GPRK1 and GPRK2, which share 
homology with members of the mammalians subfamilies 2 and 4, respectively.  GPRK1 
(more similar in sequence to mammalian GRK2 and GRK3) modulates the amplitude of 
the visual response acting as a Rhodopsin kinase [129].  GPRK2 has higher sequence 
identity with mammalian members of the GRK4 subfamily (GRK4-6), and its function 
is required to regulate the level of cAMP during Drosophila oogenesis [130, 131].  
Recent work in our laboratory using the Drosophila model revealed that when Grpk2 
levels are lowered the function of Smo is impaired.  Thus, flies expressing interference 
RNA directed against GPRK2 display a phenotype similar to that characteristic of Smo 
loss-of-function alleles [132]. Furthermore, loss of GPRK2 also affects Smo protein 
localisation and stability, suggesting that GPKK2 is required for the correct activation 
of Smo [132].  So far, no Drosophila β−arrestin homolog has been reported to affect Hh 
signaling.  In this regard, in vivo studies in vertebrates also have shown that β−arrestin 
2 acts as a positive regulator of the Hh pathway that in zebrafish [107].  However, there 
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are no data concerning the role of β−arrestin and GRKs during mammalian 
development.  Mice lacking either β-arrestin 1 or β-arrestin 2 are viable, whereas those 
lacking both are embryonic lethal [133], although the double-mutant embryos have to 
our knowledge not been examined for defects in Hh signaling.  Mice lacking Grk2 die 
between embryonic day (E) 9.0 and E15.5 with heart abnormalities [134], but again 
analysis of a potential Hh/Smo signaling-realated phenotype has not been reported.  
In sum, these results suggest that Smo regulation by GRK family members and 
subsequent β−arrestin protein interaction are important in the Hh pathway, both in 
vertebrates and invertebrates, probably involving modulation of Smo phosphorylation, 
stability and subcellular localisation (see proposed model in Figure 3).  Further research 
in both cellular and animal models will help to understand the mechanisms involved in 
the functional interaction among GRKs, β−arrestins and components of Smo signaling 
pathway, and its physiological and pathological implications.  
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Legends to Figures 
 
Figure 1 
The Hedgehog signaling network. 
(i) Right panel, signaling cell (C): Hh auto-processing generates an N-terminal domain 
with a C-terminal cholesterol motif.  Cholesterol-modified Hh can be palmitoylated at 
its N-terminal, a reaction that is catalyzed by the acyl-transferase Sightless.  Lipid-
modified Hh can be further processed at the plasma membrane, where it multimerizes. 
Multimeric Hh secretion requires the function of Disp, making Hh available for long-
range signaling. (ii) Left panel (A), non-responding cells:  In the absence of Hh, Ptc 
inhibits Smo activity.  Ptc acts by directing Smo to endocytic vesicles, where it is 
targeted for degradation.  Ci, the downstream transcription factor of the Hh pathway, is 
silenced by protein-interactions that take place in two different complexes: most of the 
Ci protein is part of a microtubule-bound multimeric complex involving Cos2, Fu and 
different kinases (as PKA, CKI and GSK3  that phosphorylate Ci, promoting its 
ubiquitination by Slimb to generate the truncated transcriptional repressor (Ci75), and its 
degradation by the proteasome in a process dependent on Debra activity. Ci75 binds 
target genes and blocks their transcription.  The other Ci pool in the cell appears as 
complexes between full-length Ci155 and Su(fu), resulting in the cytoplasmic retention 
of Ci. (iii) Central panel (B), Hh-responding cells. When Hh binds to Ptc, releases the 
repression that Ptc exerts on Smo, allowing the activation of downstream components.  
The putative co-receptors Meg, Ihog and Boi are represented to the left of Ptc.  Smo is 
phosphorylated and signals to the Cos2/Fu/Ci complex, causing hyperphosphorylation 
of Cos2 and Fu and their subsequent release from the microtubules.  Fu itself 
participates in Cos2 phosphorylation.  Stabilized Ci155 can then travel to the nucleus and 
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function as a transcriptional activator.  Smo activation also allows Su(fu) 
phosphorylation by Fu, promoting the release of full length Ci155 from Su(fu) and its 
nuclear localisation. 
 
FIGURE 2 
Alignment of Smo receptors from representative vertebrate and invertebrate 
orthologs with other members of the secretin/frizzled GPCR family.  
 
The putative regions comprising the transmembrane domains are noted in the 
alignment, as well as the cysteine-rich domain (CRD).  The phosphoserine/threonine 
residues identified in endogenous Drosophila Smo after Hh stimulation [99] are 
indicated by asterisks.  Those phospho-residues that could be phosphorylated by GRKs 
family members and are present in both Drosophila and human Smo protein are boxed.  
Amino acid sequences accession numbers are: Human-Soomothened (gi52032099), 
Drosophila-Smoothened (gi27919934), human-Frizzled-2 (gi736679) and Human-
secretin receptor (gi38609719) 
 
 
FIGURE 3 
Putative roles of β-arrestin and GRK2/Gprk2 in Smo regulation 
Smo receptor activity is constitutively inhibited by Ptc.  Upon Hh binding to Ptc 
receptor, Smo is released and rapidly phosphorylated by a G-protein coupled receptor 
kinase (GRK) family member, thus leading to β-arrestin recruitment, and receptor 
internalisation.  Once internalized, Ptc is degraded and Smo can be recycled back to the 
plasma membrane. It is tentatively speculated that in the endocytic compartment β-
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arrestin would be released, so Smo can be further phosphorylated by other kinases such 
as PKA and CKI.  As a final step, Smo receptor would be recycled in an active form to 
the plasma membrane. 
Figure 1
Figure 2
Figure 3
Drosophila Vertebrates Main features
Sonic Hedgehog (SHH)
Desert Hegehog (DHH)
Indian Hedgehog (IHH)
Rasp (Rasp) Skinny Hh (SKN) Acyl Transferase
Dispatched (Disp) Dispatched A (DISPA) Sterol-sensing domain protein
Dally and Dally-like (Dlp) ? Glypicans
Tout-velu (Ttv)
Sister of tout-velu (Sotv)
Brother of tout-velu (Botv)
Shifted (Shf) Secreted Protein
Patched 1 (PTC1)
Patched 2 (PTC2)
Interference Hedgehog (Ihog) CDO
Brother of Ihog (Boi) BOC
Megalin LDL superfamily protein
Transducter Smoothened (Smo) Smoothened (SMO) 7-TM Protein
Other Hh-binding factors Pxb Hh-interacting Protein (HIP) 1-TM Protein
KIF7
KIF3a
IFT88
IFT172
Fused (Fu) Fused (FU) S/T Kinase
Suppressor of Fused (Su(Fu)) Supressor of Fused (SUFU) Negative Regulator
Missing in metastasis (MIM) Positive Regulator
Iguana Positive Regulator
FKBP8 Negative Regulator
SIL Negative Regulator
Rab23 Negative Regulator
PKA PKA S/T Kinase
Casein Kinase I (CKI) CKI S/T Kinase
Glycogen synthase kinase 3 (GSK3 GSK3 S/T Kinase
? β-arrestin-2 GPCR Binding Protein
Slimb {beta}TrCP F-box/WD40
Gprk2 GRK2 GPCR Kinase
GLI1
GLI2
GLI3
References are indicated in the text, and can be found in the following rewiews: [3-7, 10, 11, 20, 22, 42-45, 90] and for Gprk2 in flies [132].
Table I.- Elements of the Smo signaling pathway in flies and vertebrates
Secreted Signalling Protein
Zn-finger Transcription Factor
12-TM protein
Kinesin Family Member
Intraflagellar Transport Protein
HSPGs Biosynthesis
Costal2 (Cos)
Cubitus interruptus (Ci)
Smo and/or Ci Regulators
Transcription Factors
Exotosin (EXT)
Patched (Ptc)
Co-receptors
Cytoplasmic Regulators
Fibronectin type III and Ig 
domains trans-membrane 
protein
Hedgehog (Hh)Ligands
Processing and Transport of Ligand
Receptors
Table
